Raloxifene decreases serum IGF-I in male patients with active acromegaly
European journal of endocrinology / European Federation of Endocrine Societies, Volume 150, Issue 4, 2004, Pages 481-487.
Objective: Most patients with acromegaly require additional treatments after trans-sphenoidal surgery. Although traditional methods of treatment aim at suppressing GH hypersecretion from the pituitary tumor, recent studies on the use of the GH receptor antagonist have shown that targeting the action of GH on peripheral tissues may be more...More
Full Text (Upload PDF)
PPT (Upload PPT)